GGrantIndex
← Leaderboards

Boston University Medical Campus

Boston, MA

Compare ↔
$3,618,174,074
Total funding
3,833
Grants

Funding over time

peak $239.9M · FY2005–25
$250M$187.5M$125M$62.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,579,002,054 · 3787
CDC$37,652,357 · 18
AHRQ$4,766,513 · 27
FDA$966,147 · 3
HHS (Other)$761,393 · 2

By mechanism

R01$1,665,236,883 · 847
U01$201,557,109 · 57
UC7$200,976,756 · 67
P01$153,054,917 · 157
N01$141,647,487 · 14
UC6$141,020,930 · 1

Investigators at Boston University Medical Campus

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Mohsan Saeed$3,891,3633 gr2Amelia Kent Wesselink$2,333,2573 gr3Nicole L Spartano$1,690,0181 gr4Kelly Kenzik$1,488,7671 gr5Martin Thunemann$1,178,6681 gr6Andre Fischer$1,068,5112 gr7Archana Patel$1,060,6611 gr8Andrea Geisz-Fremy$1,038,1801 gr

Emerging Leaders

6–10 yrs in

1Claudia L Satizabal$10,586,7462 gr2Markus Bosmann$8,719,8874 gr3Chunyu Liu$5,730,8865 gr4Kimberly A. Bertrand$4,800,8293 gr5Vijaya B. Kolachalama$4,422,6137 gr6Jennifer E Snyder-Cappione$4,113,9261 gr7Laura Forsberg White$3,672,3612 gr8Joshua D Campbell$3,672,0813 gr

All-Time

Most funded here, all years

1Michael D Stein$38,871,88935 gr2Philip A Wolf$38,466,9754 gr3Sudha Seshadri$37,860,15015 gr4Lynn Rosenberg$36,983,2789 gr5Jeffrey H Samet$35,296,13517 gr6Vasan S. Ramachandran$33,148,29724 gr7Benjamin L Wolozin$28,739,69622 gr8Joseph P Mizgerd$26,365,70611 gr

Largest grants

National Center/Emerging Infectous Diseases &Biodefense$128,021,180
UC6 · FY2003 · AI
The Framingham Heart Study$23,134,059
N01 · FY2008 · HL
The Framingham Heart Study$16,664,505
N01 · FY2011 · HL
The Framingham Heart Study$15,872,094
N01 · FY2009 · HL
National Emerging Infectious Diseases Laboratories Operations$13,568,475
UC7 · FY2014 · AI
National Center/Emerging Infectous Diseases & Biodefense$12,999,750
UC6 · FY2006 · AI
National Emerging Infectious Diseases Laboratories Operations$12,697,405
UC7 · FY2015 · AI
National Emerging Infectious Diseases Laboratories Operations$12,000,000
UC7 · FY2008 · AI
Novel Insights into Osteoarthritis, Pain and Function: MOST4$11,514,044
U19 · FY2023 · AG
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2023 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2019 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2022 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2021 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2016 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2024 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2025 · AI
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2020 · AI
National Emerging Infectious Diseases Laboratories Operations$11,010,956
UC7 · FY2009 · AI
National Emerging Infectious Diseases Laboratories Operations$11,000,000
UC7 · FY2011 · AI
Novel Insights into Osteoarthritis, Pain and Function: MOST4$10,060,442
U19 · FY2024 · AG